CAD 0.01
(N/A%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 37.58 Million CAD | 24.12% |
2022 | 30.27 Million CAD | -26.37% |
2021 | 41.12 Million CAD | 0.64% |
2020 | 40.86 Million CAD | -32.12% |
2019 | 60.19 Million CAD | 134.42% |
2018 | 25.67 Million CAD | 10381.42% |
2017 | 244.98 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 44.55 Million CAD | 8.58% |
2024 Q1 | 41.03 Million CAD | 9.18% |
2023 Q1 | 28.63 Million CAD | -5.43% |
2023 Q2 | 30.8 Million CAD | 7.59% |
2023 FY | 37.58 Million CAD | 24.12% |
2023 Q3 | 34.61 Million CAD | 12.35% |
2023 Q4 | 37.58 Million CAD | 8.58% |
2022 FY | 30.27 Million CAD | -26.37% |
2022 Q1 | 37.61 Million CAD | -8.53% |
2022 Q4 | 30.27 Million CAD | -15.66% |
2022 Q3 | 35.9 Million CAD | 4.15% |
2022 Q2 | 34.46 Million CAD | -8.36% |
2021 Q4 | 41.12 Million CAD | -13.9% |
2021 Q3 | 47.76 Million CAD | 33.82% |
2021 FY | 41.12 Million CAD | 0.64% |
2021 Q1 | 38.05 Million CAD | -6.87% |
2021 Q2 | 35.69 Million CAD | -6.21% |
2020 Q1 | 46.26 Million CAD | -23.14% |
2020 FY | 40.86 Million CAD | -32.12% |
2020 Q4 | 40.86 Million CAD | 8.49% |
2020 Q2 | 37.05 Million CAD | -19.92% |
2020 Q3 | 37.66 Million CAD | 1.65% |
2019 Q4 | 60.19 Million CAD | 44.0% |
2019 Q3 | 41.8 Million CAD | -61.2% |
2019 Q2 | 107.73 Million CAD | -19.27% |
2019 Q1 | 133.44 Million CAD | 419.71% |
2019 FY | 60.19 Million CAD | 134.42% |
2018 Q1 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q4 | 25.67 Million CAD | 0.0% |
2018 FY | 25.67 Million CAD | 10381.42% |
2017 FY | 244.98 Thousand CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aion Therapeutic Inc. | 2.93 Million CAD | -1179.848% |
Ayurcann Holdings Corp. | 14.31 Million CAD | -162.467% |
Blueberries Medical Corp. | 470.72 Thousand CAD | -7884.039% |
The BC Bud Corporation | 626 Thousand CAD | -5903.589% |
BioNxt Solutions Inc. | 6.55 Million CAD | -473.763% |
CordovaCann Corp. | 11.29 Million CAD | -232.858% |
Christina Lake Cannabis Corp. | 8.5 Million CAD | -342.097% |
Captor Capital Corp. | 28.76 Million CAD | -30.656% |
City View Green Holdings Inc. | 3.73 Million CAD | -906.777% |
1CM Inc. | 9.42 Million CAD | -298.811% |
Global Hemp Group Inc. | 5.82 Million CAD | -545.181% |
Greenway Greenhouse Cannabis Corporation | 21.17 Million CAD | -77.494% |
IM Cannabis Corp. | 35.11 Million CAD | -7.034% |
Lobe Sciences Ltd. | 2.45 Million CAD | -1427.99% |
Maple Leaf Green World Inc. | 10.08 Million CAD | -272.809% |
Mountain Valley MD Holdings Inc. | 258 Thousand CAD | -14466.941% |
Nextleaf Solutions Ltd. | 4.4 Million CAD | -753.502% |
Ovation Science Inc. | 728.99 Thousand CAD | -5055.435% |
Pharmadrug Inc. | 2.92 Million CAD | -1184.673% |
Captiva Verde Wellness Corp. | 2.08 Million CAD | -1699.115% |
RAMM Pharma Corp. | 2.83 Million CAD | -1225.43% |
RIV Capital Inc. | 275.63 Million CAD | 86.365% |
Revive Therapeutics Ltd. | 3.4 Million CAD | -1004.096% |
Red White & Bloom Brands Inc. | 364.63 Million CAD | 89.693% |
1933 Industries Inc. | 23.28 Million CAD | -61.418% |
Red Light Holland Corp. | 3.82 Million CAD | -883.414% |
Top Strike Resources Corp. | 20.99 Million CAD | -79.016% |
Xebra Brands Ltd. | 789.95 Thousand CAD | -4657.576% |
Adastra Holdings Ltd. | 17.65 Million CAD | -112.841% |